| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |